Flavia Adina Martin

Dr. Flavia Adina Martin

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2020 in Journal of Thermal Analysis and Calorimetry
Verified
Journal Article
Closed access
PDF file
IKIrina E. Kacsó
Irina E. Kacsó
LRLucia Maria Rus
Lucia Maria Rus
FMFlavia Adina Martin
Flavia Adina Martin
MMMaria O. Miclăuș
Maria O. Miclăuș
XFXenia Filip
Xenia Filip
MDMonica Dan
Monica Dan

Verified
Journal Article
Open access
PDF file
IBIoana Baldea
Ioana Baldea
RMRemus Moldovan
Remus Moldovan
ANAndras-Laszlo Nagy
Andras-Laszlo Nagy
Pompei BolfaPompei Bolfa
Pompei Bolfa
RDRoxana Decea
Roxana Decea
VRVlad Răzniceanu
Vlad Răzniceanu
Development of cocrystals through crystal engineering is a viable strategy to formulate poorly water-soluble active pharmaceutical ingredients as stable crystalline solid forms with enhanced bioavailability. This study presents a controlled cocrystallization process by cooling for the 1:1 cocrystal of Ketoconazole, an antifungal class II drug with the Fumaric acid coformer. This was successfully set up following the meta-stable zone width determination in acetone–water 4:6 (V/V) and pure ethanol. Considering the optimal crystallization data, laboratory scale-up processes were carried out at 1 g batch size, efficiently delivering the cocrystal in high yields up to 90% pure and single phase as revealed by powder X-ray diffraction. Biological assays in vitro showed improved viability and oxidative damage of the cocrystal over Ketoconazole on human dermal fibroblasts and hepatocarcinoma cells; in vivo, on Wistar rats, the cocrystal increased oral Ketoconazole bioavailability with transient minor biochemical transaminases increases and without histological liver alterations. Locally on Balb C mice, it induced no epicutaneuous sensitization. A molecular docking study conducted on sterol 14α-demethylase (CYP51) enzyme from the pathogenic yeast Candida albicans revealed that the cocrystal interacts more efficiently with the enzyme compared to Ketoconazole, indicating that the coformer enhances the binding affinity of the active ingredient.

1 June 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
FMFlavia Adina Martin
Flavia Adina Martin
Daniel MARCONIDaniel MARCONI
Daniel MARCONI
SNSilvia Neamtu
Silvia Neamtu
TRTeodora Radu
Teodora Radu
Monica FlorescuMonica Florescu
Monica Florescu
ITIoan Turcu
Ioan Turcu

4 June 2021 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
Sorina DanescuSorina Danescu
Sorina Danescu
Gabriela Adriana FilipGabriela Adriana Filip
Gabriela Adriana Filip
RMRemus Moldovan
Remus Moldovan
EOElena Diana Olteanu
Elena Diana Olteanu
ANAndras-Laszlo Nagy
Andras-Laszlo Nagy
IBIoana Baldea
Ioana Baldea

4 September 2025 in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
FMFlavia Adina Martin
Flavia Adina Martin
MMMaria O. Miclăuș
Maria O. Miclăuș
AGAna Maria Raluca Gherman
Ana Maria Raluca Gherman
MDMonica Dan
Monica Dan
IGIoana Grosu
Ioana Grosu
IKIrina E. Kacsó
Irina E. Kacsó
Objective: This research aimed to investigate the compatibility of the Ketoconazole-Adipic Acid (KTZ-AA) co-crystal, which exhibits an improved dissolution profile over pure Ketoconazole, with various solid pharmaceutical excipients, as well as its in silico antifungal potential. Methods: Binary physical mixtures (1:1 w/w) of KTZ-AA co-crystal and excipients were analyzed using differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), Fourier-transform infrared spectroscopy (FT-IR), and powder X-ray diffraction (PXRD). The molecular docking study targeting the sterol 14α-demethylase (CYP51) enzyme of the pathogenic yeast Candida albicans was performed. Results: DSC results indicated compatibility between co-crystal and six tested excipients: lactose monohydrate, polyvinylpyrrolidone K90, microcrystalline cellulose, corn starch, colloidal silicon dioxide, and talc. In the case of the co-crystal and magnesium stearate mixture, DSC revealed a change in the thermal behavior, suggesting the formation of a eutectic system. However, TGA demonstrated that the decomposition profile of the co-crystal remained unaffected in all binary mixtures. PXRD and FT-IR further confirmed the absence of chemical interactions between the co-crystal and all excipients under ambient conditions. Moreover, the KTZ-AA co-crystal maintained its chemical stability without degradation after three months storage under accelerated conditions (40°C/75% RH). The molecular docking study demonstrated that co-crystallization of KTZ with AA enhances its binding affinity to CYP51 enzyme compared to KTZ alone. Conclusion: The excipient compatibility study conducted on the Ketoconazole-Adipic Acid co-crystal confirmed its potential for development as a solid oral dosage form with improved antifungal activity, presenting a promising alternative to the parent drug.

25 March 2022 in Acta Crystallographica Section C Structural Chemistry
Verified
Journal Article
Closed access
PDF file
IGIoana Georgeta Grosu
Ioana Georgeta Grosu
FMFlavia Adina Martin
Flavia Adina Martin
ATAlexandru Turza
Alexandru Turza
MMMaria O. Miclăuș
Maria O. Miclăuș
IKIrina E. Kacsó
Irina E. Kacsó
GBGheorghe Borodi
Gheorghe Borodi